Insulin oral - Diabetology

Drug Profile

Insulin oral - Diabetology

Alternative Names: Capsulin; Capsulin IR; Capsulin OAD; DTY001

Latest Information Update: 10 Dec 2015

Price : $50

At a glance

  • Originator Diabetology
  • Class Antihyperglycaemics; Insulins; Pancreatic hormones
  • Mechanism of Action Ornithine decarboxylase stimulants; Phosphokinase stimulants; Tyrosine aminotransferase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Type 1 diabetes mellitus; Type 2 diabetes mellitus

Most Recent Events

  • 10 Dec 2015 Diabetology plans a phase IIb trial for Type-2 diabetes mellitus
  • 07 Aug 2015 Phase-II development for Type 1 diabetes mellitus and Type 2 diabetes mellitus is ongoing in United Kingdom
  • 24 Jul 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top